Development of a Mobile Health Intervention for Electronic Cigarette Use Among Young Adults

Launched by UNIVERSITY OF CHICAGO · Apr 26, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a new mobile health program designed to help young adults who use electronic cigarettes (also known as e-cigarettes or ENDS) and are interested in quitting or reducing their use. Many young adults want to stop using these products, but there are not many effective resources available to help them. The trial aims to see if this mobile health approach can effectively support their goal of quitting or cutting back on e-cigarette use.

To participate in this trial, you need to be between 18 and 26 years old, able to read and understand English, and currently using e-cigarettes at least four days a week. You should also be interested in quitting or reducing your use. The study will not include anyone who has certain serious mental health conditions or who is currently pregnant or breastfeeding. If you join, you can expect to receive support through your mobile phone, which may include text messages and helpful materials related to quitting. This program is a promising step towards better support for young adults looking to reduce their dependence on e-cigarettes.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Age 18-26 years old, ability to understand the English language, willing and able to provide informed consent
• • 2. Current ENDS user (at least 4 out of 7 days per week of use for the past one month); for focus groups, at least half of participants will report current cigarette smoking (at least 1 cigarette per day on at least 1 day per week in the past month)
• • 3. Report interest in quitting or reducing ENDS (at least 6/10 scale in interest of quitting or reducing
• • 4. Does not currently (in past one year) meet criteria for major psychiatric disorder including severe alcohol or substance use disorder (excluding tobacco use disorder), schizophrenia, bipolar disorder, and obsessive compulsive disorder
• • 5. For women, not currently pregnant, planning to become pregnant, or breastfeeding due to lack of information on ENDS use and possible harms from NRT during pregnancy
• • 6. Not currently using smoking cessation medication (i.e., Varenicline, Bupropion
• • 7. No history of adverse reactions to nicotine replacement therapy
• Exclusion Criteria:
• • 1. Does not own a mobile phone or is unwilling to receive text messages to their device
• • 2. No interest in quitting or reducing use of ENDS
• • 3. Uses electronic cigarettes less than 4 days per week in the past month
• • 4. Reports past-year serious psychiatric illness, including severe alcohol or substance use disorder (excluding tobacco use disorder), schizophrenia, bipolar disorder, and obsessive compulsive disorder
• • 5. Is currently using smoking cessation medication including Varenicline or Bupropion
• • 6. Are a female who is currently pregnant or nursing or planning to become pregnant within the next 6 months